Fleury Group

Fleury Group, founded in 1926, stands as a premier medical and health organization in Brazil, specializing in clinical laboratories and diagnostic medicine. The company maintains a reputation for technical, medical, and management excellence, serving as a cornerstone of the Brazilian healthcare infrastructure. By integrating advanced diagnostic technologies with patient-centric care, Fleury Group has established itself as a leader in the medical testing sector, consistently delivering high-quality clinical services across its extensive network.

The organization operates at a significant scale, managing a network of approximately 185 care units under various brands, including A+ Diagnostic Medicine, Weinmann Laboratory, Labs a+, Felippe Mattoso Clinic, Diagnoson a+, Serdil, and the Institute of Radiology. With a workforce exceeding 10,000 employees and a dedicated team of over 2,000 physicians, Fleury Group ensures comprehensive medical coverage and operational efficiency. This vast infrastructure supports a wide range of diagnostic services, catering to both B2B and B2C segments while maintaining rigorous quality standards across all clinical facilities.

Beyond its diagnostic operations, Fleury Group actively fosters innovation through initiatives like the PIF, which recognizes national health-focused projects. The company’s commitment to medical advancement is reflected in its strategic management and continuous investment in healthcare technology. Meet Fleury Group's team to learn more about the leadership driving these clinical advancements and the organizational structure supporting their expansive operations. As a key player in the South American healthcare market, Fleury Group continues to prioritize patient outcomes and scientific rigor, solidifying its position as a trusted provider in the evolving landscape of diagnostic medicine.